Moreover, the expression of TGF-β and its activity correlates with androgen receptor signaling during prostate inflammation [22], and modulation of this pathway proved protective against androgen-mediated BPH progression [20,51]. The gene discussed is TGFB1; the disease is benign prostatic hyperplasia.